Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schwinger

Showing results (651-660 of 680) with videos related to

Pageof 68
Sort By:
British Journal of Haematology|July 21, 2018
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trialMichaela Kuhlen, Peter Bader, Martin Sauer, et al.
Current Climate Change Reports|August 25, 2020
Tracking Improvement in Simulated Marine Biogeochemistry Between CMIP5 and CMIP6Roland Séférian, Sarah Berthet, Andrew Yool, et al.
Frontiers in Immunology|July 18, 2018
No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair DeficiencyVictoria K Tesch, Hanna IJspeert, Andrea Raicht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II TrialTim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
American Journal of Human Genetics|October 7, 2000
A major locus for myoclonus-dystonia maps to chromosome 7q in eight familiesC Klein, K Schilling, R J Saunders-Pullman, et al.
Thrombosis and Haemostasis|September 23, 2016
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) TrialDirk Sibbing, Dániel Aradi, Claudius Jacobshagen, et al.
International Journal of Cardiology|May 1, 2014
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensusM S Nieminen, J Altenberger, T Ben-Gal, et al.
Internal and Emergency Medicine|November 19, 2025
Troponin predicts mortality in heart failure-related cardiogenic shockBenedikt N Beer, Jonas Sundermeyer, Lisa Besch, et al.
International Journal of Cardiology|May 19, 2015
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisationsMarkku S Nieminen, Kenneth Dickstein, Cândida Fonseca, et al.
International Journal of Cardiology|August 8, 2016
Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paperDimitrios Farmakis, Julian Alvarez, Tuvia Ben Gal, et al.
Pageof 68

Showing results (651-660 of 680) with videos related to

Sort By:
Pageof 68
British Journal of Haematology|July 21, 2018
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trialMichaela Kuhlen, Peter Bader, Martin Sauer, et al.
Current Climate Change Reports|August 25, 2020
Tracking Improvement in Simulated Marine Biogeochemistry Between CMIP5 and CMIP6Roland Séférian, Sarah Berthet, Andrew Yool, et al.
Frontiers in Immunology|July 18, 2018
No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair DeficiencyVictoria K Tesch, Hanna IJspeert, Andrea Raicht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II TrialTim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
American Journal of Human Genetics|October 7, 2000
A major locus for myoclonus-dystonia maps to chromosome 7q in eight familiesC Klein, K Schilling, R J Saunders-Pullman, et al.
Thrombosis and Haemostasis|September 23, 2016
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) TrialDirk Sibbing, Dániel Aradi, Claudius Jacobshagen, et al.
International Journal of Cardiology|May 1, 2014
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensusM S Nieminen, J Altenberger, T Ben-Gal, et al.
Internal and Emergency Medicine|November 19, 2025
Troponin predicts mortality in heart failure-related cardiogenic shockBenedikt N Beer, Jonas Sundermeyer, Lisa Besch, et al.
International Journal of Cardiology|May 19, 2015
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisationsMarkku S Nieminen, Kenneth Dickstein, Cândida Fonseca, et al.
International Journal of Cardiology|August 8, 2016
Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paperDimitrios Farmakis, Julian Alvarez, Tuvia Ben Gal, et al.
Pageof 68